EGRX  valuation analysis

Basics
Name: Eagle Pharmaceuticals Inc
Description: Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 09, 2021
Market cap: $717.42M (1308th)
Sales(TTM): $179.14M (1352nd)
Earnings(TTM): $5.63M (1192nd)

Value
FFER: 1.09 (why)
Actual price: $54.86
FFEThis is Eagle Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $50.28
Quantile: EGRX is expensive given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry